FAIRFIELD, Conn., June 17, 2008 (PRIME NEWSWIRE) -- Competitive Technologies, Inc. (AMEX:CTT) announced today that they will be making presentations in California to the investment communities in San Diego, Newport Beach and San Francisco, recognizing the increased investor interest from individuals and institutions:
Thursday June 19 San Diego Westgate Hotel Friday June 20 Newport Beach The Daily Grill Wednesday June 25 San Francisco Le Meridien Hotel
"We will be in California for the BIO International Convention in San Diego from June 17 - 20 to display our pain management therapy device, a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs," said John B. Nano, CTT's Chairman, President and CEO.
"CTT's management team is focused on generating profitable revenue growth from its technologies, building shareholder value, establishing global alliances, and maximizing the dynamic opportunities of our technologies. We are aggressively marketing the pain management therapy device, breast cancer detection test, MC Square stress reduction device (www.relaxmc.com), solar panels, and UAD surgical prosthetics technologies to drive revenue growth, improve profitability and create shareholder value. Our full technology portfolio may be viewed on our website."
About Competitive Technologies, Inc.
Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTT is a global leader in identifying, developing and commercializing innovative technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net
Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2007, filed with the SEC on October 29, 2007, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.